Phase I study of AZD6738, an inhibitor of ataxia telangiectasia Rad3-related (ATR), in combination with olaparib or durvalumab in patients (pts) with advanced solid cancers Meeting Abstract
| Authors: | Krebs, M. G.; Lopez, J.; El-Khoueiry, A.; Bang, Y. J.; Postel-Vinay, S.; Abida, W.; Carter, L.; Xu, W.; Im, S. A.; Pierce, A.; Frewer, P.; Berges, A.; Cheung, S. Y. A.; Stephens, C.; Felicetti, B.; Dean, E.; Hollingsworth, S. J. |
| Abstract Title: | Phase I study of AZD6738, an inhibitor of ataxia telangiectasia Rad3-related (ATR), in combination with olaparib or durvalumab in patients (pts) with advanced solid cancers |
| Meeting Title: | 109th Annual Meeting of the American Association for Cancer Research (AACR) |
| Journal Title: | Cancer Research |
| Volume: | 78 |
| Issue: | 13 Suppl. |
| Meeting Dates: | 2018 Apr 14-18 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2018-07-01 |
| Language: | English |
| ACCESSION: | WOS:000468818900025 |
| DOI: | 10.1158/1538-7445.Am2018-ct026 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: CT026 -- Source: Wos |
